Tremelimumab
Product Specifications
CAS Number
745013-59-6
Target
Others, Immunology/Inflammation related
Related Pathways
Immunology/Inflammation, Others
Purity
0.987
Bioactivity
Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and lung cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog